Epclusa 61958-2205-01

Generic: Velpatasvir And Sofosbuvir

Package NDC

61958-2205-01

Product NDC: 61958-2205

Manufacturer: Gilead Sciences, Inc.
Dosage Form: Pellet
Route: Oral
Product Type: Human Prescription Drug
Marketing Start: June 10, 2021
Listing Expires: December 31, 2026
Application: NDA214187

Need to source Epclusa? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Sofosbuvir	150 mg/1
Velpatasvir	37.5 mg/1

Drug Class

Hepatitis C Virus NS5A Inhibitor [EPC]Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]Breast Cancer Resistance Protein Inhibitors [MoA]

Selected Package

61958-2205-01Selected

28 PACKET in 1 CARTON (61958-2205-1) / 1 PELLET in 1 PACKET